GenMont Biotech Incorporation (TPE:3164)
15.45
-1.05 (-6.36%)
Nov 20, 2026, 1:30 PM CST
| Market Cap | 1.33B -15.8% |
| Revenue (ttm) | 396.64M +1.3% |
| Net Income | 62.01M +79.8% |
| EPS | 0.71 +81.6% |
| Shares Out | 86.01M |
| PE Ratio | 21.76 |
| Forward PE | n/a |
| Dividend | 0.80 (5.18%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 41,058 |
| Open | 16.00 |
| Previous Close | 16.50 |
| Day's Range | 15.45 - 16.20 |
| 52-Week Range | 15.35 - 19.75 |
| Beta | 0.05 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 11, 2027 |